Abstract:Introduction: Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. Areas covered: In this review, we provide a status update on COVID-19 vaccines currently undergoing clinical trials and discuss issues of concern beyond vaccine efficacy and safety, including dosing regimens, the mixed vaccine strategy, prior severe acute respiratory syndrome coronavirus-2 infection, antibody levels, cellular immunity and protection, variants of concern, COVID-19 vaccine distribution, vaccination willingness, herd immunity, immunity passports, and vaccine indications. Expert opinion: Four vaccines have obtained emergency use authorization, 87 are at the clinical development stage, and 186 are in pre-clinical development. While the knowledge and development of COVID-19 vaccines is rapidly expanding, the benefits of COVID-19 vaccines must outweigh the potential risks of adverse events. To combat the COVID-19 pandemic, clinicians should consistently update COVID-19-associated information, and healthcare authorities and manufacturers should work together to provide adequate and appropriate vaccinations for the prevention of COVID-19. Plain language summary: What is the context?Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused a global pandemic: the coronavirus disease 2019 (COVID-19) outbreak. The development and implementation of the COVID-19 vaccine could be an important measure to control the COVID-19 pandemic.What is new?Several phase 3 clinical trials have demonstrated the effectiveness and safety of COVID-19 vaccines for the prevention of SARS-CoV-2 infections. Several COVID-19 vaccines have obtained emergency use authorization and been implemented in many countries. Although concerns regarding unusual blood clots and low platelet counts have been raised, the benefits of COVID-19 vaccines outweigh the potential risks of adverse events.What is the impact?Except for children, the COVID-19 vaccine is recommended for all people, including those pregnant or immunocompromised. Healthcare authorities should advise people receiving the vaccine that they must seek medical attention if they have associated thromboembolism and thrombocytopenia symptoms. More studies are necessary to determine the appropriate vaccine dose and regimen strategy, as well as the effectiveness of COVID-19 vaccines against variants of concerns. A global effort must be made to achieve widespread vaccination and herd immunity.

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2

COVID-19 vaccines: concerns beyond protective efficacy and safety

The COVID-19 Vaccines: Recent Development, Challenges and Prospects

Status Report on COVID-19 Vaccines Development

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development

COVID-19 vaccine updates for people under different conditions

COVID-19: Understanding the New Variants of Concern

The way of SARS-CoV-2 vaccine development: success and challenges

Challenges and Recent Advancements in COVID-19 Vaccines

Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

COVID-19: Coronavirus Vaccine Development Updates

Coronavirus vaccine development: from SARS and MERS to COVID-19

Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

COVID-19 Variants and Vaccine Development

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines